Deep Tech Startups

EMXYS designs and manufactures high-performance electronic systems for space applications including satellite systems, defence equipment, and scientific instrumentation. The company addresses societal challenges through advanced space technology and embedded systems.

1 investor

EnaChip develops integrated magnetic structures — thin, small inductors fabricated with semiconductor-compatible electroplating — for point-of-load power delivery in AI infrastructure, advanced packaging, chiplets, and edge systems. Its platform brings magnetics into PMIC/IVR packages and the chip stack to improve power efficiency and density for compute systems.

1 investor

Enantios develops analytical instrumentation and solutions for pharmaceutical and chemical research laboratories. The company serves scientists and researchers who need advanced molecular analysis tools to support laboratory decision-making.

1 investor

Enartin designs and develops custom mechanical systems and tools from concept to production, serving industrial companies, startups, and aerospace sector clients with bespoke solutions for engineering challenges not found in standard catalogs.

1 investor

Encapsys develops microencapsulation technology used to add specific characteristics to consumer and industrial products, serving companies across sectors such as agrochemicals and consumer goods. It offers custom-developed encapsulation solutions backed by scientific research and manufacturing facilities.

1 investor

EnCoat is a research and technology organisation developing antifouling coating solutions aimed at improving efficiency, environmental sustainability, and cost-effectiveness for the maritime and coating industry. Part of the Scanventure group, it works to translate university research into industry-ready products, including reducing copper use in antifouling coatings.

1 investor

Endeavour Aerospace is an Australian company developing dual-use aerospace technology, including solid rocket motors, propulsion, avionics, and guidance and control systems. It also operates the Red Sands Launch Range in the Australian Outback, with rocket motor products planned for 2027.

1 investor

Endlyz develops small-molecule disease-modifying therapeutics targeting the ATP13A2 and ATP10B lysosomal transporters to restore endo-lysosomal function and counter neurodegeneration. Its initial focus is genetic subsets of Parkinson's disease, with plans to expand into sporadic Parkinson's and other dementias.

1 investor

Endurion builds mission-critical systems for national security and defense operations in the United States, combining operational expertise with AI-enabled analytics and technology platforms. The company serves defense and security missions where reliability under pressure is required.

1 investor

ENERCON provides multidisciplinary engineering, technical analysis, and regulatory services for energy and infrastructure projects, including operating and advanced nuclear plants, grid integration, thermal assets, and data center power and cooling. It serves utilities, nuclear operators, developers, and hyperscalers across the project lifecycle from site assessment to operational support.

1 investor

Korial provides a software platform that orchestrates fleets of robots, drones, and sensors for autonomous industrial operations, monitoring, diagnosing, and acting on data across critical facilities. It targets industrial leaders and operators of essential services and critical infrastructure such as refineries, chemical plants, power stations, and offshore platforms.

1 investor

EnerzAI is an AI company, founded in 2019, that provides technology to improve AI model performance across accuracy, speed, cost efficiency, and sustainability. It offers optimization capabilities for organizations' AI initiatives.

1 investor

Engidi builds ACRUX, an IoT wearable device that connects to workers and provides real-time data on their location and health to help companies monitor and reduce safety risks in industrial settings. It serves industries such as petrochemicals, electricity, mining, road maintenance, civil works, and rescue teams.

1 investor

Engimmune develops soluble TCR therapeutic candidates using AI-guided innovation and protein engineering for oncology and immunotherapy applications. The company was founded by veteran biotherapeutics developers and focuses on unlocking therapeutic potential through its differentiated technology platform.

1 investor

Enhanced Drilling produces EC-Monitor, a real-time well monitoring system that tracks volume fluctuations and detects anomalies in drilling operations. The system is designed for offshore and deepwater drilling environments where precise pressure and kick/loss detection are critical for safety.

1 investor

Enigma develops robotics foundation AI models, a hardware-agnostic abstraction layer, and user interfaces that let humans control and interact with robots. Its technology is designed to run on any robot form factor, from warehouse arms to humanoids, and is sold to robotics hardware companies that build the physical machines.

1 investor

Enjamb develops an agentic AI platform for biopharma R&D teams that automates drug discovery, trial execution, and regulatory filings. The platform integrates with existing systems to support programs from early discovery through FDA approval.

1 investor

Ennoventure provides covert, cryptographic authentication signals embedded invisibly into product packaging artwork using standard printing equipment and conventional inks, verifiable via any smartphone. It serves brands for anti-counterfeiting and brand protection, offering AI-based verification, market intelligence analytics, and integration through APIs and SDKs.

1 investor

ENPICOM provides a software platform for biologics discovery that orchestrates analysis workflows, handles immune-repertoire and antibody sequence analysis, and integrates assay and sequencing data for drug development scientists and teams. The platform processes billions of sequences and delivers results directly to scientists without requiring dedicated bioinformatics support.

1 investor

ENSEM Therapeutics develops small molecule precision medicines for oncology using its Kinetic Ensemble platform, which combines computational and AI/deep learning methods with experimental techniques to identify cryptic binding pockets. The company focuses on structure-based drug design for high-value, difficult-to-drug targets.

1 investor

Entact is a drug discovery company developing treatments for patients. It works in the biotechnology and therapeutics sector.

1 investor

Enthought provides scientific computing services, enterprise scientific software development, and digital transformation for science, applying Python, AI/machine learning, and simulation to research and R&D problems. It serves organizations in sectors such as pharmaceuticals, materials, and semiconductors, with operations in the U.S. and Japan.

1 investor

Enumera Molecular develops technology and a platform for simplified, lower-cost workflows that enable liquid biopsy and high-dimensional omics assays for laboratories. It targets clinical labs performing molecular diagnostics.

1 investor

Countable Labs (formerly Enumerix) develops a digital PCR platform that performs genetic analysis with higher sensitivity, precision, and dynamic range than legacy PCR methods. The technology serves oncology, NIPT (non-invasive prenatal testing), infectious disease, and cell and gene therapy applications.

1 investor